Trial Profile
The prospective study of denosumab for the treatment of osteoporosis in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 22 May 2020 Status changed from active, no longer recruiting to completed.
- 16 May 2016 New trial record